Literature DB >> 29296448

Dosimetric comparison of intracranial metastasis treatment using two radiosurgery systems: TrueBeam STx with VMAT and Gamma Knife Model 4C.

Vance Keeling1, Ozer Algan1, Salahuddin Ahmad1, Sabbir Hossain1.   

Abstract

We compared treatment plan quality based on target coverage and normal brain tissue sparing for two intracranial stereotactic radiosurgery systems: TrueBeam STx using VMAT and Gamma Knife (GK). Ten patients with 24 tumors (seven with 1-2 and three with 4-6 ranging from 0.1 to 20.2 cc), previously treated with GK Model 4C (prescription doses ranging from 14-23 Gy), were re-planned for VMAT using Eclipse treatment planning system. Various photon beam energies and MLC leaf widths with and without jaw tracking were studied to achieve optimal plans. Plan qualities were assessed by target coverages using Paddick Conformity Index (PCI), normal-brain-tissue integral dose (Gy-cc) and sparing. In all cases critical structure dose criteria were met. The average PCI was 0.76±0.21 for VMAT and 0.46±0.20 for GK plans (p≤0.001), respectively. On average 81% reduction of 12 Gy normal-brain-tissue volumes was achieved by VMAT. The average integral dose ratio of GK to VMAT plans was 1.50±0.61 (p=0.006). VMAT was capable of producing higher quality treatment plans in terms of target coverage and normal brain tissue sparing than GK while using optimal beam geometries and optimization techniques.

Entities:  

Keywords:  Gamma Knife; RapidArc; VMAT; beam optimization; brain metastases

Year:  2016        PMID: 29296448      PMCID: PMC5658806     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  21 in total

1.  Commissioning of photon beams of a flattening filter-free linear accelerator and the accuracy of beam modeling using an anisotropic analytical algorithm.

Authors:  Jan Hrbacek; Stephanie Lang; Stephan Klöck
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-02       Impact factor: 7.038

2.  A method for optimizing LINAC treatment geometry for volumetric modulated arc therapy of multiple brain metastases.

Authors:  Jun Kang; Eric C Ford; Koren Smith; John Wong; Todd R McNutt
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

3.  A flattening filter free photon treatment concept evaluation with Monte Carlo.

Authors:  U Titt; O N Vassiliev; F Pönisch; L Dong; H Liu; R Mohan
Journal:  Med Phys       Date:  2006-06       Impact factor: 4.071

4.  Properties of unflattened photon beams shaped by a multileaf collimator.

Authors:  Falk Pönisch; Uwe Titt; Oleg N Vassiliev; Stephen F Kry; Radhe Mohan
Journal:  Med Phys       Date:  2006-06       Impact factor: 4.071

5.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

Review 6.  Current status and future perspective of flattening filter free photon beams.

Authors:  Dietmar Georg; Tommy Knöös; Brendan McClean
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

7.  Dosimetric characteristics of 6 and 10MV unflattened photon beams.

Authors:  Gabriele Kragl; Sacha af Wetterstedt; Barbara Knäusl; Mårten Lind; Patrick McCavana; Tommy Knöös; Brendan McClean; Dietmar Georg
Journal:  Radiother Oncol       Date:  2009-07-09       Impact factor: 6.280

8.  Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

Authors:  L S Chin; L Ma; S DiBiase
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

9.  Dosimetric effects of jaw tracking in step-and-shoot intensity-modulated radiation therapy.

Authors:  Sarah Joy; George Starkschall; Stephen Kry; Mohammed Salehpour; R Allen White; Steven H Lin; Peter Balter
Journal:  J Appl Clin Med Phys       Date:  2012-03-08       Impact factor: 2.102

10.  Assessment of potential jaw-tracking advantage using control point sequences of VMAT planning.

Authors:  Jung-in Kim; Jong Min Park; So-Yeon Park; Chang Heon Choi; Hong-Gyun Wu; Sung-Joon Ye
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.